| Specific lymphocyte subsets predict response to adoptive cell therapy using expanded autologous tumor-infiltrating lymphocytes in metastatic melanoma patients LG Radvanyi, C Bernatchez, M Zhang, PS Fox, P Miller, J Chacon, R Wu, ... Clinical Cancer Research 18 (24), 6758-6770, 2012 | 455 | 2012 |
| Prospective analysis of adoptive TIL therapy in patients with metastatic melanoma: response, impact of anti-CTLA4, and biomarkers to predict clinical outcome MA Forget, C Haymaker, KR Hess, YJ Meng, C Creasy, T Karpinets, ... Clinical Cancer Research 24 (18), 4416-4428, 2018 | 121 | 2018 |
| A novel method to generate and expand clinical-grade, genetically modified, tumor-infiltrating lymphocytes MA Forget, RJ Tavera, C Haymaker, R Ramachandran, S Malu, M Zhang, ... Frontiers in immunology 8, 285318, 2017 | 60 | 2017 |
| Parallel profiling of immune infiltrate subsets in uveal melanoma versus cutaneous melanoma unveils similarities and differences: a pilot study Y Qin, M Petaccia de Macedo, A Reuben, MA Forget, C Haymaker, ... Oncoimmunology 6 (6), e1321187, 2017 | 51 | 2017 |
| Utilizing T-cell activation signals 1, 2, and 3 for tumor-infiltrating lymphocytes (TIL) expansion: the advantage over the sole use of interleukin-2 in cutaneous and uveal melanoma RJ Tavera, MA Forget, YU Kim, D Sakellariou-Thompson, CA Creasy, ... Journal of Immunotherapy 41 (9), 399-405, 2018 | 41 | 2018 |
| Intrathecal administration of tumor-infiltrating lymphocytes is well tolerated in a patient with leptomeningeal disease from metastatic melanoma: a case report IC Glitza, C Haymaker, C Bernatchez, L Vence, M Rohlfs, J Richard, ... Cancer immunology research 3 (11), 1201-1206, 2015 | 32 | 2015 |
| Intrathecal Administration of Tumor-Infiltrating Lymphocytes Is Well Tolerated in a Patient with Leptomeningeal Disease from Metastatic Melanoma: A Case Report. Cancer Immunol … IC Glitza, C Haymaker, C Bernatchez, L Vence, M Rohlfs, J Richard, ... The largest cohort of melanoma LMD patients treated with intrathecal …, 0 | 8 | |
| The impact of checkpoint blockade prior to adoptive cell therapy using tumor-infiltrating lymphocytes for metastatic melanoma: An update from MD Anderson Cancer Center. MA Forget, CL Haymaker, KR Hess, J Roszik, SE Woodman, OJ Fulbright, ... Journal of Clinical Oncology 35 (7_suppl), 138-138, 2017 | 2 | 2017 |
| Linking Publications to Instruments, Field Campaigns, Sites and Working Groups: The ARM Experience D Troyan, AT Cialella, L Gregory, K Lazar, M Liang, L Ma, A Tilp, ... AGU Fall Meeting Abstracts 2017, IN33B-0107, 2017 | | 2017 |
| lymphocytes for metastatic melanoma: An update from MD Anderson Cancer Center MA Forget, CL Haymaker, KR Hess, J Roszik, SE Woodman, OJ Fulbright, ... JOURNAL OF CLINICAL ONCOLOGY 35 (7), 2017 | | 2017 |
| Adoptive Cell Therapy Using Expanded Autologous Tumor-infiltrating Lymphocytes in Metastatic Melanoma Patients: Role of Specific Lymphocyte Subsets C Bernatchez, M Zhang, PS Fox, JA Chacon, CH Wu, G Lizee, ... JOURNAL OF IMMUNOTHERAPY 35 (9), 721-721, 2012 | | 2012 |
| Specific lymphocyte subsets predict response to adoptive cell therapy using expanded autologous tumor-infiltrating lymphocytes in 2 metastatic melanoma patients 3 JC Miller, R Wu, G Lizee, S Mahoney, G Alvarado, M Glass, VE Johnson, ... | | |
